Table 1 Baseline clinical characteristics of 33 patients with liver cirrhosis
| Â | All | Child-Pugh class A/B | Child-Pugh class C | P value |
|---|---|---|---|---|
N = 33 | N = 10 | N = 23 | ||
Age (years) | 56.3 ± 9.9 | 58.8 ± 7.3 | 55.3 ± 10.8 | 0.355 |
Male (n, %) | 25 (75.8%) | 9 (90.0%) | 16 (69.6%) | 0.208 |
Systolic blood pressure (mmHg) | 113.47 ± 14.0 | 111.5 ± 7.6 | 114.4 ± 16.2 | 0.601 |
Diastolic blood pressure (mmHg) | 66.3 ± 12.3 | 60.9 ± 9.0 | 68.8 ± 12.9 | 0.094 |
Heart rate (/min) | 73.6 ± 15.7 | 63.3 ± 9.1 | 78.0 ± 16.0 | 0.002 |
Cirrhosis etiology (n, %) | Â | Â | Â | 0.296 |
 Viral | 20 (60.6%) | 8 (80.0%) | 12 (52.2%) |  |
  HBV | 17 (51.5%) | 6 (60.0%) | 11 (47.8%) |  |
  HCV | 3 (9.1%) | 2 (20.0%) | 1 (4.3%) |  |
 Alcoholic | 9 (27.3%) | 1 (10.0%) | 8 (34.8%) |  |
 Autoimmune hepatitis | 2 (6.1%) | 0 (0%) | 2 (8.7%) |  |
 Cryptogenic | 2 (6.1%) | 1 (10.0%) | 1 (4.3%) |  |
 Child-Pugh score | 9.8 ± 2.4 | 6.8 ± 1.3 | 11.1 ± 1.2 | < 0.001 |
 MELD score | 18.8 ± 7.4 | 11.1 ± 2.1 | 22.1 ± 6.3 | < 0.001 |
Underlying diseases (n, %) | ||||
 Hypertension | 8 (24.2%) | 4 (40.0%) | 4 (17.4%) | 0.164 |
 Diabetes mellitus | 9 (27.3%) | 4 (40.0%) | 5 (21.7%) | 0.279 |
Medication (n, %) | ||||
 Beta-blockers | 8 (24.2%) | 6 (60.0%) | 2 (8.7%) | 0.002 |
 Diuretics | 17 (51.5%) | 4 (40.0%) | 13 (56.5%) | 0.383 |
 ACEI/ARB | 3 (9.1%) | 2 (20%) | 1 (4.3%) | 0.151 |
Laboratory examination | ||||
 Hemoglobin (g/dL) | 10.6 ± 1.6 | 11.4 ± 1.6 | 10.2 ± 1.5 | 0.050 |
 Creatinine (mg/dL) | 0.9 ± 0.4 | 0.8 ± 0.2 | 0.9 ± 0.4 | 0.565 |
 Bilirubin (mg/dL) | 7.5 ± 8.5 | 1.7 ± 0.6 | 10.0 ± 9.1 | < 0.001 |
 Albumin (g/dL) | 2.9 ± 0.4 | 3.2 ± 0.4 | 2.7 ± 0.4 | 0.002 |
 PT (INR) | 1.9 ± 1.0 | 1.3 ± 0.2 | 2.1 ± 1.1 | 0.001 |